America Great Health (AAGH)

USD 0.0

(-18.18%)

Revenue Summary of America Great Health

  • America Great Health's latest annual revenue in 2023 was 204.3 Thousand USD , up 95.23% from previous year.
  • America Great Health's latest quarterly revenue in 2024 Q3 was 94.03 Thousand USD , up 3.13% from previous quarter.
  • America Great Health reported a annual revenue of 104.64 Thousand USD in annual revenue 2022, down -46.52% from previous year.
  • America Great Health reported a annual revenue of 195.67 Thousand USD in annual revenue 2021, up 3474.55% from previous year.
  • America Great Health reported a quarterly revenue of 94.03 Thousand USD for 2024 Q3, up 3.13% from previous quarter.
  • America Great Health reported a quarterly revenue of 13.8 Thousand USD for 2024 Q1, down -81.51% from previous quarter.

Annual Revenue Chart of America Great Health (2023 - 2011)

Historical Annual Revenue of America Great Health (2023 - 2011)

Year Revenue Revenue Growth
2023 204.3 Thousand USD 95.23%
2022 104.64 Thousand USD -46.52%
2021 195.67 Thousand USD 3474.55%
2020 5474.00 USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD -100.0%
2016 3.17 Million USD 7219.05%
2015 43.37 Thousand USD 0.0%
2014 - USD -100.0%
2013 6627.00 USD 47.27%
2012 4500.00 USD 0.0%
2011 - USD 0.0%

Peer Revenue Comparison of America Great Health

Name Revenue Revenue Difference
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -5007.7%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 67.729%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -90.942%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.643%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -211.198%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD 61.451%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.675%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 98.304%
Trevena, Inc. 3.12 Million USD 93.462%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 64.156%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -638.908%